Role of Social Determinants and Outcomes of Patients with Alcohol-Associated Liver Disease Referred for Early Liver Transplantation: A Multicenter Analysis社会决定因素在早期转诊进行肝移植的酒精性肝病患者的结局中的作用:一项多中心分析American Journal of TransplantationIF8.22025-12-290PRE
Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH ConsortiumTRANSPLANTATIONIF52024-10-220PRE
Blood Testing for Phosphatidylethanol血液检测磷脂酰乙醇JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552024-06-180PRE
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case reportAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22023-03-010OA
Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapyHEPATOLOGY COMMUNICATIONSIF4.62022-08-2510OAAI
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United StatesJOURNAL OF HEPATOLOGYIF332021-12-01265PREAI
Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver DiseaseCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122021-06-0145PREAI
Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation EvaluationHEPATOLOGY COMMUNICATIONSIF4.62020-12-279OAAI
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver ForumHEPATOLOGYIF15.82019-10-2962OAAI
iLFT: A big assist in the recognition of liver disease in general practiceJOURNAL OF HEPATOLOGYIF332019-10-010PREAI
Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk PatientsAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62019-01-2928PREAI
Cylindrical Battery Ingestion: Emergent Endoscopic Retrieval or Patient Observation? A Case Report and Literature ReviewAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62017-10-010PRE
Using modelling & simulation to integrate mouse PK-PD-efficacy with preliminary human PK data to inform the Phase II doses and schedule for the experimental c-Met inhibitor AZD6094 (Volitinib)EUROPEAN JOURNAL OF CANCERIF7.12014-11-012PREAI